Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Whelan

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|March 8, 2012
For you, commissar, the war is overPeter Whelan
European Urology|November 7, 2006
Are we entering the era of truly minimally invasive destructive techniques for the treatment of urologic tumours and will these therapies stay in urologists' hands?Peter Whelan
European Urology|September 25, 2007
Bladder cancer--contemporary dilemmas in its managementPeter Whelan
The Practitioner|October 14, 2006
Manage urinary tract infectionsPeter Whelan
European Urology|February 26, 2008
Endocrine events in prostate cancer: a paradigm shift in our understanding?Peter Whelan
European Urology|June 10, 2008
Editorial comment on: Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker-results from a 1-yr, multicentre, randomised, phase 2 dose-finding study in the treatment of prostate cancerPeter Whelan
European Urology|February 5, 2008
Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Peter Whelan
Annals of the Royal College of Surgeons of England|May 28, 2005
The case against radical prostatectomyPeter Whelan
European Urology|May 12, 2007
The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancerPeter Whelan
Expert Opinion on Pharmacotherapy|October 26, 2010
Triptorelin embonate: a 6-month formulation for prostate cancerPeter Whelan
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|March 8, 2012
For you, commissar, the war is overPeter Whelan
European Urology|November 7, 2006
Are we entering the era of truly minimally invasive destructive techniques for the treatment of urologic tumours and will these therapies stay in urologists' hands?Peter Whelan
European Urology|September 25, 2007
Bladder cancer--contemporary dilemmas in its managementPeter Whelan
The Practitioner|October 14, 2006
Manage urinary tract infectionsPeter Whelan
European Urology|February 26, 2008
Endocrine events in prostate cancer: a paradigm shift in our understanding?Peter Whelan
European Urology|June 10, 2008
Editorial comment on: Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker-results from a 1-yr, multicentre, randomised, phase 2 dose-finding study in the treatment of prostate cancerPeter Whelan
European Urology|February 5, 2008
Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Peter Whelan
Annals of the Royal College of Surgeons of England|May 28, 2005
The case against radical prostatectomyPeter Whelan
European Urology|May 12, 2007
The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancerPeter Whelan
Expert Opinion on Pharmacotherapy|October 26, 2010
Triptorelin embonate: a 6-month formulation for prostate cancerPeter Whelan
Pageof 5